...
首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency.
【24h】

Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency.

机译:重组生长激素(GH)治疗对成年儿童生长激素缺乏症成人的骨矿物质密度和身体组成的影响。

获取原文
获取原文并翻译 | 示例

摘要

Lumbar spine, whole proximal femur and total body bone mineral density (BMD, g/cm2) and the regional soft tissue composition were measured with dual energy X-ray absorptiometry (Hologic QDR 1000/W) in eight adults with childhood onset GHD, before and after 6 months of recombinant GH treatment (0.5 IU/kg/week). Data obtained from patients were compared with those recorded in an age and sex matched control group. Before treatment, lumbar (L2-L4) spine BMD (mean +/- SD: 0.811 +/- 0.159 g/cm2), whole proximal femur BMD (0.739 +/- 0.094 g/cm2) and total body BMD (0.946 +/- 0.087 g/cm2) of patients were significantly (p < 0.001, 0.01 and 0.001, respectively) lower than those recorded in an age- and sex-matched control group (1.077 +/- 0.155 g/cm2, 0.968 +/- 0.166 g/cm2 and 1.168 +/- 0.058 g/cm2, respectively), although three patients showed BMD values at the lower limit of the normal range. Mean lumbar spine BMD, whole proximal femur BMD and total body BMD did not significantly change alter 6 months' GH treatment (-1.4 +/- 3.7%, +2.7 +/- 3.7% and -1.1 +/- 5.0% vs basal values, respectively). On the other hand, trochanteric subregion showed a significant 4.8 +/- 5.3% increase (vs basal, p < 0.05), while other hip subregions did not show significant changes. GH therapy caused marked effects on body composition; in fact, a significant decrease (p < 0.01) of trunk fat (-25.2 +/- 15.0%) and a marked increase (p < 0.01) of limbs lean mass (+10.0 +/- 5.3%), resulting in a significant (p < 0.02) reduction (-16.5 +/- 13.5%) of the axial to peripheral fat ratio (APFR), were clearly evident after six months of therapy. In conclusion, our study shows that six months of GH treatment do not exert relevant effects on the BMD of adults with childhood onset GHD. On the contrary, the effects of GH therapy on body composition are more marked, being clearly appreciable after six months of treatment.
机译:使用双能X线骨密度仪(Hologic QDR 1000 / W)对8例儿童期发病为GHD的成年人进行腰椎,股骨近端和全身骨矿物质密度(BMD,g / cm2)以及局部软组织成分的测量。经过6个月的重组GH治疗(0.5 IU / kg /周)。将从患者获得的数据与年龄和性别匹配的对照组中记录的数据进行比较。治疗前,腰(L2-L4)脊柱BMD(平均+/- SD:0.811 +/- 0.159 g / cm2),整个股骨近端BMD(0.739 +/- 0.094 g / cm2)和全身BMD(0.946 + / -0.087 g / cm2)的患者显着(分别为p <0.001、0.01和0.001)低于年龄和性别匹配的对照组(1.077 +/- 0.155 g / cm2,0.968 +/- 0.166) g / cm2和1.168 +/- 0.058 g / cm2),尽管三名患者的BMD值处于正常范围的下限。在6个月的GH治疗后,平均腰椎BMD,股骨近端BMD和全身BMD没有明显变化(相对于基础值,分别为-1.4 +/- 3.7%,+ 2.7 +/- 3.7%和-1.1 +/- 5.0% , 分别)。另一方面,股骨转子区显示出明显的4.8 +/- 5.3%的增加(相对于基础,p <0.05),而其他髋关节区没有显示出明显的变化。 GH疗法对身体成分产生明显影响;实际上,躯干脂肪显着减少(p <0.01)(-25.2 +/- 15.0%),肢体瘦体重显着增加(p <0.01)(+10.0 +/- 5.3%),导致显着增加治疗六个月后,轴向与周围脂肪比率(APFR)降低了(p <0.02)(-16.5 +/- 13.5%)。总之,我们的研究表明,GH治疗六个月并未对儿童期GHD成年人的BMD产生相关影响。相反,GH疗法对身体组成的影响更为明显,在治疗六个月后明显可见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号